News Search

Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.

Columbia bioengineers and surgeons have developed a technique in animal models that overcomes a long-standing hurdle in lung regeneration.